Consultant Cardiologist and current director for clinical governance for the surgery, cancer and cardiovascular division at Imperial College Healthcare NHS Trust. Special interest in coronary artery disease and runs the heart attack centre at the Trust.
General Medicine Sub Speciality: Structural and Interventional Cardiology
NHS Hospital Positions
- Consultant Cardiologist, Hammersmith Hospital, Cardiovascular Medicine, Imperial College Healthcare NHS Trust (ICHNT)
- Director of Quality and Safety, Surgery-Cancer-Cardiovascular Division, ICHNT
- Clinical Lead for TAVI, ICHNT
- Honorary Senior Lecturer, International Centre for Circulatory Health, Imperial College , London
Dr Malik’s clinical interests are in the assessment of chest pain, shortness of breath, and hypertension. He has specialist interest in coronary artery disease (the cause of angina) and its treatment with simple and complex coronary angioplasty including rotablation and chronic total occlustions (CTOs). In addition, with increasing treatments being made available for valve disease and stroke, Dr Malik performs ASD, PFO, LAA closure and TAVI procedures.
He leads the large Heart Attack Centre (HAC) program at Hammersmith Hospital, delivering world class treatment to patients in West London, and performs a large volume of structural heart procedures, both at Hammersmith Hospital and at the Wellington and BUPA Cromwell Hospitals.
He is a proctor for PFO closure, Paravalvular Leak closure and TAVI procedures.
As part of his role at Hammersmith Hospital, he as implemented many audit projects and Information Technology Systems to improve patient safety.
Education and Training
1987 BA (1st Class Hons) (Cambridge)
1990 MB BChir (Cambridge)
1994 MA (Cambridge)
1994 MRCP (UK)
2003 CCST in Cardiology and General Internal Medicine
2010 Clinical Excellence Bronze Award
Dr Malik studied undergraduate medicine at the University of Cambridge and Guy’s Hospital, London. His medical specialist training was in West London, with a research fellowship in Cardiovascular Medicine at Hammersmith Hospital and Imperial College leading to a PhD. He has since been awarded FRCP from the Royal College of Physicians, London, and an MA from Cambridge University. He took sabbaticals in Germany and Italy to complete his clinical training.
Dr Malik was appointed Consultant Cardiologist at St Mary’s Hospital and Honorary Senior Lecturer at Imperial College in 2003. Following the merger of St Mary’s, Hammersmith and Charing Cross Hospitals with Imperial College, he began to practice at all these hospitals. In 2010 he has appointed lead for the Heart Attack Treatment program, and in 2011, he became Director of the Cardiac Catheter Laboratories at Hammersmith Hospital.
He also has clinics in Harrow for the Primary Care Trust (PCT) and Harrow Health, a model of care delivered by the Specialist reaching out to the community, in tandem with Specialist GPs.
Dr Malik’s research interests are in the Coronary Artery Disease and Structural Heart Disease. He has been involved in assessing coronary disease using invasive pressure and flow measurements to increase the accuracy of diagnosis. The role of PFO closure in Migraine is being actively assessed, as the disease burden of migraine is large. Dr Malik is a founding member of the International Centre for Circulatory Health (ICCH), a centre of research excellence in Imperial College London.
He has a keen interest in Stroke and Heart Disease prevention, and has been involved in many trials:
- CARDia Trial: PCI (angioplasty) vs CABG (bypass) in Diabetes
- MIST Trial: PFO closure in Migraine
- PRIMA Trial: PFO closure in Migraine
- PC Trial: PFO closure in Stroke
- ROBOT-PFO Trial PFO closure using radiofrequency ablation
- ICSS Trial: Carotid artery stenting (CAS) vesus carotid end-arterectomy (CEA)
- ACST-2 Asymptomatic Carotid patients CAS versus CEA
- Olympia Registry: Drug Eluting Stents (DES) in coronary disease
- Export Study: Clot extraction in Primary Angioplasty
- CURRENT-OASIS7 Anti-platelet drugs in Acute Coronary Syndromes
- TRA-CER Anti-platelet drugs in Acute Coronary Syndromes
- NIAPP Primary Angioplasty delivery in the UK
- NOBLE: Left main stem (LMS) PCI vs CABG
- SYNTAX-2-Use of iFR functional assessment to manage coronary disease with stents
- ORBITA- Assess medical therapy with stents in coronary disease
- BRAVO trial-Use of bivalirudin in TAVI
- UK TAVI trial- use of TAVI in lower risk patients with aortic stenosis
Dr Malik has been invited to lecture nationally and internationally in the field interventional cardiology. He has set up and run international courses to train doctors in General Cardiology (with BMJ Masterclass), Stroke Prevention (with BMJ Masterclass) and Valve disease (TheImperial Valve Course). He has also been involved with Courses using virtual reality technology to train doctors (with the British Cardiovascular Society and Academia, Medtronic Inc.)
He has taken part in many live case demonstrations, and is often in the spotlight when cardiovascular topics arise in the UK media.
Dr Malik was National Clinical Lead for Web-Transfer systems for the NHS Heart Improvement Program. He has designed and helped implement a major system to reduce waiting times for heart patients.
He was Revascularisation Lead for the North West London Cardiac and Stroke Network, helping improve patient care across West London.
He set up a training program for workers in the cardiac catheter laboratories to allow them to multiskill, so that patient treatment could be improved. This has since been taken up nationally by the British Cardiovascular Society and London South Bank University.
He was Commissioning Editor for Heart (the British Heart Journal) until retiring from this role in 2010.
He is part of the Pan London Collaborative improving Heart Attack Treatment in liason with the London Ambulance Service.
He is a clinical advisor on the NHS England London Strategic Clinical Advisory Group (SCLG) for Cardiovascular Medicine. He is interested in Out of Hospital Cardiac Arrest management, and the treatment of Kawasaki Disease in Adults.